论文部分内容阅读
目的分析23G微创全玻璃体切除术治疗增殖期糖尿病视网膜病变(PDR)的疗效。方法回顾性分析江门市五邑中医院2012年6月1日至2015年6月1日收治的66例PDR患者的临床资料,根据不同治疗方案分为两组各33例;对照组予20G全玻璃体切除术,研究组予23G微创全玻璃体切除术,对比两组手术时间、手术前后眼压与视力情况。结果两组手术前后组内、组间眼压比较差异均未见统计学意义(P>0.05);研究组手术时间短于对照组(P<0.05);两组术前、术后各时间点视力情况组间比较差异均未见统计学意义(P>0.05);两组术后3、6个月较术前视力均得以改善(P<0.05)。结论 23G全玻璃体切除术具备手术时间短、微创等优点,应用于PDR患者治疗安全有效,值得临床推广应用。
Objective To analyze the curative effect of 23G minimally invasive total vitrectomy on proliferative diabetic retinopathy (PDR). Methods The clinical data of 66 PDR patients admitted to Wuyi Traditional Chinese Medicine Hospital of Jiangmen City from June 1, 2012 to June 1, 2015 were retrospectively analyzed. According to the different treatment plans, the data were divided into two groups of 33 cases. The control group was given 20G Vitrectomy, the study group to 23G minimally invasive total vitrectomy, compared two groups of operation time, intraocular pressure and visual acuity before and after surgery. Results There was no significant difference in intraocular pressure between the two groups before and after operation (P> 0.05). The operation time of the study group was shorter than that of the control group (P <0.05). The preoperative and postoperative time points There was no significant difference in visual acuity between the two groups (P> 0.05). The visual acuity of the two groups was improved at 3 and 6 months after operation (P <0.05). Conclusion 23G total vitrectomy with short operative time, minimally invasive and other advantages, for the treatment of PDR patients safe and effective, worthy of clinical application.